by Maria Dalby: Self-management after undergoing transplantation requires skills and confidence both with respect to taking medications, adhering to medical advice and coping with everyday life.
by Maria Dalby: Advances in diagnostic techniques, genetic testing and immunosuppressive protocols allow clinicians to tailor interventions to the individual patient’s needs to a greater extent than in… read more.
The majority of patients presenting with MM are elderly and pose a considerable clinical challenge in terms of disease burden and comorbidities compared with their younger counterparts. A… read more.
Gene expression profiling (GEP) is currently the best approach for defining risk in multiple myeloma (MM). Mutation detection may be used for improving risk stratification and providing additional… read more.
Specialists in the MM field are in the enviable position of having lots of different treatment options available – the challenge is how to integrate these into the… read more.
Multiple myeloma is unique amongst cancers in that the diagnosis is made by the clinician, not the pathologist. The pathologist merely states that the patient has a clonal… read more.
IMW President, Professor Antonio Palumbo (Torino, Italy) gives his highlights, along with Dr Noopar Raje (Boston, USA) , Professor Faith Davies, (Little Rock, USA) and Professor Paul Richardson (Boston, USA).
Non-adherence with immunosuppressive treatment is potentially one of the most significant risk factors for intra-patient variability (IPV) in drug concentrations – and one that is modifiable. The link… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
